AstraZeneca in $560 m deal for respir...

AstraZeneca in $560 m deal for respiratory firm

There are 1 comment on the Seattle Times story from Jun 10, 2013, titled AstraZeneca in $560 m deal for respiratory firm. In it, Seattle Times reports that:

British drugmaker AstraZeneca PLC says it is to acquire Pearl Therapeutics Inc., a Redwood-City, California-based company involved in therapies for asthma and chronic obstructive pulmonary disease for at least $560 million.

Join the discussion below, or Read more at Seattle Times.

Since: Apr 13

Location hidden

#1 Jun 10, 2013
This sounds promising.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Biotech Discussions

Title Updated Last By Comments
News Bristol Palin says abstinence best path for teens (May '09) Wed Robby Rob 2,650
News Myriad Genetics Announces an Assay that Identif... Nov 24 Purplemouse2 2
News Pfizer, Allergan in deal talks to create drug g... (Oct '15) Nov 18 Fubar 5
News Emotiv Insight, A Wireless Headset Designed to ... Nov 13 InteraxonMuse8753... 1
News RPT-Trump presidency could prove a salve for ph... Nov 12 Philosophic 2
News States With the Worst Sex Education Nov 5 PubertatHvordanIk... 2
News Seattle Genetics Demonstrates Commitment to Imp... Oct '16 Rockstar 2
More from around the web